हिंदी में पढ़ें
Income Tax Calculator
Personal Loan Calculator
Car Loan Calculator
Home Loan Calculator
MF Returns Calculator
Laurus Labs News
Laurus Labs: Anil Singhvi reveals powerful strategy for investors ahead of quarterly results announcement
Tue, Apr 27, 2021
Zee Business Managing Editor Anil Singhvi said that Laurus Labs is expected to post strong quarterly numbers on 29th April. Market Expert, Rakesh Bansal said that ahead of results, this stock can be purchased with stop-loss of Rs 433
Stocks to Buy with Anil Singhvi – Experts Kunal Saraogi, Rakesh Bansal pick Laurus Labs as their Special Pick for today
Tue, Apr 13, 2021
Stocks to Buy with Anil Singhvi – Laurus Labs - Stock Market Experts Kunal Saraogi and Rakesh Bansal today gave yet another Special Pick which they said will bring windfall gains for the investors. The experts said that the pharma stocks are now in focus. The stock picked today was Laurus Labs. Know why these experts are bullish on this stocks and what gains is it expected to give to the investors
Laurus share price: Antique Stock Broking initiates coverage with a Buy rating and a target price of Rs 574
Wed, Apr 07, 2021
Laurus Labs share price today is Rs 420, up Rs 23.5 or 6%. Laurus Labs share price has moved up from Rs 359 to Rs 420 in the last one week. Antique Stock Broking says that Laurus Labs is a leading research driven manufacturing Company. With process chemistry and R&D as its core Laurus has successfully gained leadership in various (Antiretroviral) ARV APIs and formulations in Low Middle Income Countries
Laurus Labs share price: Sharekhan retains Buy recommendation with a revised price target of Rs 450
Thu, Mar 11, 2021
Sharekhan had an interaction with Laurus Labs management and their commentary was positive, pointing towards a robust growth outlook. Laurus’ formulations business is on a strong growth footing, backed by a higher quantum of launches in the US as well as opportunities from in-licensing of products, in addition to traction in anti-retrovirals (ARVs).
Laurus Labs share price: Anand Rathi maintains Buy rating with target price of Rs 424 per share
Mon, Feb 01, 2021
Anand Rathi maintains Buy rating on Laurus Labs with a target price of Rs 424 per share. Laurus Lab reported consolidated revenues of Rs 12880 mn showcasing strong growth of 76% for the quarter and Rs 34020 mn for 9M FY21 growing by 71% driven by growth in all the divisions.
Laurus Labs Share price target Rs 410: Robust growth outlook, says Sharekhan
Wed, Dec 23, 2020
Laurus’ formulations business is gaining traction with the tender business, which accounts for around three-fourth of total formulation sales, and is witnessing sturdy growth. Moreover, Laurus is expanding capacities, primarily through brownfield expansions to cater to increasing demand. The first leg of debottlenecking is expected to be completed by Q4FY2021-end, while the second leg would be completed in two phases by September 2021 and December 2021. Cumulatively, the formulations capacity would increase by 80% in the next two years.
Laurus Labs Share Price: Company forays into Lucrative Biotech Space
Fri, Nov 27, 2020
The acquisition is likely to be positive for Laurus as it highly compliments the company’s aggressive growth plans and also offers a new revenue stream. Laurus’s existing business is also on a strong footing with the formulations segment being a key growth driver. The acquisition of RLPL abates concerns around utilisation of higher cash on Laurus’s books and this bodes well.
Super-Exclusive Interview: Anil Singhvi in chat with Laurus Labs' Founder and CEO Satyanarayana Chava
Fri, Oct 30, 2020
The strong results of Q2 are because of the hard work of the entire team and the capex incurred by the company during the inception and over the years.
Laurus Labs set for stock trading debut from December 19
Sun, Dec 18, 2016
Drugmaker Laurus Labs, which raised about Rs 1,332 crore through its initial public offer (IPO), is all set to make a debut on the stock exchanges on Monday.
Laurus Labs IPO fully subscribed
Thu, Dec 08, 2016
On NSE, at 1.55 pm, the IPO's qualified institutional buyers (QIB) segment was subscribed by 1.28 times with over 79 lakh of bid received for 61.74 lakh shares issued.
Is Laurus Lab IPO a good deal for investors?
Tue, Dec 06, 2016
Akash Jain, Research Analyst at Ajcon Global said, “At the upper price band, the IPO is valued at 30x at H1FY17 annualised Post issue EPS which is at a premium to its peers.”
Laurus Labs' Rs 1,332-crore IPO to hit market on December 6
Sun, Dec 04, 2016
Pharmaceutical firm Laurus Labs will hit the capital market this week to raise an estimated Rs 1,332 crore through its initial public offering (IPO). The IPO is scheduled to open on December 6 and close on December 8.